From the boardroom to the consulting room: pharma’s role in curing gender bias

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Jayasree K. Iyer, Executive Director, Access to Medicine Foundation • Pharma companies putting greater priority on women makes sense financially and in terms of healthcare impact. • Women in low-income countries bear a disproportionate disease burden. • More […]

Quelling antimicrobial resistance: a clinico-pharmacological exigency

This article was exclusively written for The European Sting by Mr. Pat Ashinze, an Igbo-Yoruba Nigerian penultimate medical student at The University of Ilorin, Ilorin, Nigeria. He is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not […]

Pharmaceuticals in the environment: Commission defines actions to address risks and challenges

This article is brought to you in association with the European Commission. The European Commission adopted yesterday a Communication outlining a set of actions addressing the multifaceted challenges that the release of pharmaceuticals poses to the environment. The “Strategic Approach to Pharmaceuticals in the Environment” that the Commission presents today, identifies six action areas concerning all […]

How we can win the war against antibiotic resistance

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Kristina Lagerstedt, Founder and CEO, 1928 Diagnostics In 1945, Sir Alexander Fleming received the Nobel Prize in Medicine for the discovery of penicillin. In Sir Alexander’s acceptance remarks, he spoke of the responsibility that accompanied that discovery, namely that […]

Sponsored content: when QUALITY meets OPEX in manufacturing

BARCELONA, July 15, 2015 – QUALITY is a key driver in timely product launches, enhancing a company’s reputation and maximizing shareholder value. Therefore Fleming Europe has decided to exploit the potential of producing an uninterrupted supply of high-quality medicine for patients in a challenging regulatory environment. How successful are you in facilitating continuous improvement of […]